首页 | 本学科首页   官方微博 | 高级检索  
     


2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man
Authors:Olpin S E  Pollitt R J  McMenamin J  Manning N J  Besley G  Ruiter J P N  Wanders R J A
Affiliation:(1) Department of Neonatal Screening and Chemical Pathology, Sheffield Children's Hospital, Sheffield, UK;(2) Department of Neonatal Screening and Chemical Pathology, Sheffield Children's Hospital, Sheffield, S10 2TH, UK;(3) Department of Paediatrics, Our Lady's Hospital for Sick Children, Dublin, Ireland;(4) The Willink Biochemical Genetics Laboratory, Royal Manchester Children's Hospital, Manchester, UK;(5) AMC Laboratory Genetic Metabolic Diseases, Amsterdam, The Netherlands
Abstract:
2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.178) deficiency is a recently described defect of isoleucine catabolism. The disorder is characterized by normal early development followed by a progressive loss of mental and motor skills. Deterioration may be rapid or may follow a slower decline with a possible stabilization of the disorder on a low-protein diet and appropriate medication. We report a 23-year-old man with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency with a very mild clinical course. He had apparently normal early development and remained relatively well until the age of 6 years, when he contracted measles. Following this illness, his motor skills and school progress deteriorated. At 15 years he had significant dysarthria, and generalized rigidity with some dystonic and unusual posturing. He was then treated with a low-protein high-carbohydrate diet with a good response in terms of balance and gait. At 18 years he was given benzhexol (Artane), increased slowly from 2thinspmg to 6thinspmg daily, resulting in improvement in tremor and dystonia. At 23 years he can dress himself and works in sheltered employment but remains severely dysarthric.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号